The different reduction rate of prostate-specific antigen in dutasteride and finasteride. - Wikidata - awgldk - TriplyDB

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

http://www.wikidata.org/entity/Q34239009

about

Efficacy and Safety of Dutasteride in Chinese Adults with Symptomatic Benign Prostatic Hyperplasia : A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study with an Open-Label Extension.The new insight of prostate-specific antigen reduction during finasteride therapy in aging men.Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors.Impact of treatment with statins on prostate-specific antigen and prostate volume in patients with benign prostatic hyperplasia.Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy.

P2860

Q39116956-6DD90B36-294B-44D2-AFBD-0FB465DE4A04 Q40120927-CB682653-F432-445F-94D1-AC34A71E1320 Q41996680-9EE2F576-771C-45F5-A52F-EA3D9BBC2357 Q43708471-0060C49C-60A1-43C3-ACA9-77A4F3BD00E9 Q50045232-7E874977-C575-453B-9C61-C6EB875C994E

P2860

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

http://www.wikidata.org/entity/Q34239009

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

@ast

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

@en

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

@nl

type

label

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

@ast

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

@en

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

@nl

prefLabel

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

@ast

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

@en

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

@nl

P1433

Q34239009-ED7D95E6-31D3-4454-A72A-23AED004554F

P1476

Q34239009-E8065EAD-0A5B-4F5B-A8BB-9D91639358B8

P2093

Q34239009-521FA3CD-69B4-4290-ACEC-FBC672E3B311

Q34239009-95D50A28-3D79-49D9-8D60-DFF8CB3C4CF0

Q34239009-9E8E3C5A-EE11-47F4-BD88-F148A4BAD4D4

P2860

Q34239009-040F0C81-3BA9-4487-94DD-05719FD47164

Q34239009-1657AC79-F5D3-433F-83EC-1F023912BDEA

Q34239009-1AC69A6E-188B-4AAF-8146-2FD7CACCB0BB

Q34239009-4CE1712A-F5B6-46F9-A745-33C94D29F8AC

Q34239009-51B8A223-9446-4882-8692-885D6DD1ED46

Q34239009-5C12959F-82E3-4CA6-A0D6-8A8C12AA5779

Q34239009-5E182298-03D5-4331-ACDA-7DEAEF5074FB

Q34239009-6CFF2005-8905-40A5-AC49-55CC1D538ACF

Q34239009-7C01915A-711F-4592-9C0D-E77A94A56BE9

Q34239009-9776A771-0DB3-41CC-A6D7-8C74E8030DEA

P304

Q34239009-C2FBCA75-EE31-46E2-86D1-1B001E0BFE0F

P31

Q34239009-AAA3D09A-1F21-486F-88B9-2BAE18ED1725

P356

Q34239009-86A28D47-6CC0-44FA-925C-7E58B4769F12

P433

Q34239009-A8EED220-DA68-44CE-9ACA-4F9FD3FB7FC9

P478

Q34239009-9E5A1D44-8E7F-4417-8161-A55E3E2736EC

P577

Q34239009-2E0E76A3-27F1-4A0E-A317-86813FF3D04C

P5875

Q34239009-36233292-845A-4044-8FB1-C6A401D13F76

P698

Q34239009-0B8C42DF-1F54-48B4-AC84-4775480B8E38

P932

Q34239009-CF46706B-7FB3-49D8-A9CA-36D8EF912EB7

P356

KJU.2010.51.10.704

P1433

Korean journal of urology

P1476

The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

@en

P2093

In Rae Cho

http://www.w3.org/2001/XMLSchema#string

Sung Yong Cho

http://www.w3.org/2001/XMLSchema#string

Yong Hyeuk Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of dutasteride on the risk of prostate cancer.

Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.

Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.

Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors.

Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer.

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.

A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.

Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume

Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.

Changes in molecular forms of prostate-specific antigen during treatment with finasteride.

P304

704-708

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4111/KJU.2010.51.10.704

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47622069

http://www.w3.org/2001/XMLSchema#string

P698

21031091

http://www.w3.org/2001/XMLSchema#string

P932

2963784

http://www.w3.org/2001/XMLSchema#string